Upward Trends in Breast Cancer Incidence Continuing Among Women
TUESDAY, Oct. 1, 2024 (HealthDay News) — Upward trends in breast cancer incidence among...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 4537 results for 'Breast cancer'
#VisualAbstract: Pembrolizumab Increases Survival in Early-Stage Triple-Negative Breast Cancer
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
1. The 5-year OS rate for pembrolizumab vs placebo was 86.1% vs 81.7% with HR 0.51 (significant)....
Read More
DESTINY-Breast12: T-DXd Exhibits Clinical Activity in HER2+ Breast Cancer Irrespective of Brain Metastases
T-DXd exhibited substantial and durable clinical activity in a large cohort of patients with metastatic HER2+ breast cancer, irrespective of brain metastases,
Read MoreDatopotamab deruxtecan may be a novel improvement for inoperable breast cancer
1. Compared to chemotherapy, patients with inoperable hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer receiving the antibody-drug conjugate (ADC) datopotamab deruxtecan...
Read More
Therapies and Proposed Management Pathway for LC in Breast Cancer
The following is a summary of “A Comprehensive Review of Current Treatment Modalities for...
Read More
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast Cancer
THURSDAY, Sept. 19, 2024 (HealthDay News) — For patients with early-stage triple-negative...
Read More
FDA Expands Use of Breast Cancer Drug Kisqali
WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Women with early-stage breast cancer may now...
Read More
Aromatase Inhibitors Not Linked to CAC in Postoperative Breast Cancer Patients
TUESDAY, Sept. 17, 2024 (HealthDay News) — For postoperative patients with breast cancer,...
Read MoreAdvertisement
Moderate Hypofractionation Shows Good Safety Outcomes in Breast Cancer
MONDAY, Sept. 16, 2024 (HealthDay News) — For patients with breast cancer, moderate...
Read MoreNeutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer.
The aim of this study was to elucidate the clinical significance of peripheral blood biomarkers, including absolute lymphocyte count (ALC) and neutrophil-to-lymphocyte ratio (NLR), at the end of treatment (EOT) with CDK4/6...
Read MoreLatent Profiles of Fear of Cancer Recurrence in Breast Cancer Patients of Reproductive Age and Associations With Reproductive Concerns.
To identify distinct profiles of fear of cancer recurrence (FCR) among breast cancer patients of reproductive age, investigate the relationship between these profiles and reproductive concerns and explore potential risk factors...
Read MoreSocioeconomic inequalities in uptake of outreach mammography before and after accessibility improvement of Taiwan’s national universal breast cancer screening policy.
Taiwan implemented the Cancer Screening Quality Improvement Program (CAQIP) in 2010. The program sought to enhance mass breast cancer screening accessibility. This study aimed to examine socioeconomic disparities in outreach...
Read MoreBreast Cancer Rises Among Asian American and Pacific Islander Women
Christina Kashiwada was traveling for work during the summer of 2018 when she noticed a small, itchy lump in her left breast. She thought little of it at first. She did routine self-checks and kept up with medical appointments....
Read MoreCausality between autoimmune diseases and breast cancer: a two-sample Mendelian randomization study in a European population.
The incidence of autoimmune diseases and breast cancer is significantly higher in women compared to men. Previous observational studies have not conclusively determined the relationship between these two conditions. This study...
Read More
Medication-related osteonecrosis of the jaw is prevalent in patients with breast cancer
1. The cumulative incidence of medication-related osteonecrosis of the jaw (MRONJ) in patients...
Read More
Benefits of Radiotherapy Last a Decade for Early Breast Cancer
WEDNESDAY, Aug. 21, 2024 (HealthDay News) — For women with early breast cancer, radiotherapy...
Read More
Digital App Aids Weight Loss and Increases Physical Activity in Breast Cancer Survivors
A mobile behavior change app produced clinically significant weight loss, increased physical activity, and improved body image in breast cancer survivors.
Read More
Breast Cancer Screening Attendance Helps Boost Other Cancer Screenings
WEDNESDAY, Aug. 14, 2024 (HealthDay News) — Offering self-sampling kits to women overdue for...
Read More
Novel Embedding Approach Enhances Breast Cancer Diagnostics and Treatment
EMBER’s ability to integrate diverse transcriptomic datasets into a common, relevant space marks a big step forward in breast cancer diagnostics and treatment.
Read More